Bruker (BRKRP) Capital Expenditures (2010 - 2026)

Bruker has reported Capital Expenditures for 17 years, with the latest figure at $24.2 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 6.92% year-over-year to $24.2 million; the trailing twelve-month figure through Mar 2026 stood at $89.0 million (down 25.77% YoY), and the FY2025 full-year result was $90.8 million, down 21.25% from the prior year.
• Capital Expenditures for Q1 2026 stood at $24.2 million, up from $22.6 million in the prior quarter.
• The five-year high for Capital Expenditures was $57.7 million in Q3 2022, with the low at $17.9 million in Q2 2022.
• Historically, Capital Expenditures has averaged $27.4 million across 5 years, with a median of $24.6 million in 2024.
• Annual changes were most pronounced in 2022 — Capital Expenditures surged 253.99% — and 2023, when it slumped 53.38%.
• Bruker's Capital Expenditures stood at $34.6 million in 2022, then dropped by 8.96% to $31.5 million in 2023, then increased by 16.51% to $36.7 million in 2024, then tumbled by 38.42% to $22.6 million in 2025, then rose by 7.08% to $24.2 million in 2026.
• The last three Capital Expenditures figures came in at $24.2 million (Q1 2026), $22.6 million (Q4 2025), and $20.9 million (Q3 2025), per Business Quant data.